Drug intelligence / Profile preview

Naoling Pian

Development stage: Unknown
Lead developer: Heilongjiang University of Chinese Medicine
Administration: Oral

Overview

Naoling Pian is a traditional Chinese medicine (TCM) prescription composed of 15 herbal ingredients, primarily indicated for the treatment of insomnia. It is considered a multi-herb formula, not a single-compound pharmaceutical, and is patented as a Chinese medicine. The exact chemical constituents of Naoling Pian are diverse (over 200 identified by high-throughput LC-MS methods[1][4][9]) and have not been fully characterized, but it is used clinically for its sedative and hypnotic effects in managing insomnia[1][7]. The mechanism of action is based on traditional Chinese medicine principles rather than a specific molecular target typical of Western pharmaceuticals; no defined monomolecular or receptor-mediated mechanism is established in biomedical literature.

Brand names: Naoling Pian
Other names: NLP

Beyond the preview

Go deeper on Naoling Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naoling Pian.

Explore the full profile